2012 projects

PATH transforms global health through innovation, working on hundreds of projects and collaborating with hundreds of partners to improve global health every day. Our largest 2012 projects are featured below.

Emerging and epidemic diseases

PATH reduces the burden of epidemic diseases—including HIV/AIDS, malaria, and tuberculosis (TB)—as well as emerging threats such as pandemic influenza.

AIDS, Population, and Health Integrated Assistance Plus Western Kenya: This community-based project promotes healthy behaviors and increases the use of health services in selected Kenyan provinces.

AIDS Support and Technical Resources Contracts: This work addresses global HIV/AIDS priorities, including HIV prevention, care, and treatment support in resource-constrained settings.

Arise Project—Enhancing HIV Prevention for At-Risk Populations: PATH is working with partners across five countries to avert new HIV infections among most-at-risk populations.

Khusela Project: PATH and our partners are improving the quality, availability, and use of services that prevent mother-to-child transmission of HIV in South Africa.

Malaria Control and Evaluation Partnership in Africa (MACEPA): MACEPA supports sub-Saharan African countries in rapidly scaling up and sustaining the impact of malaria prevention and control efforts.

Reducing the TB Burden in Ukraine: This project focuses on strengthening the quality of the national TB control program and providing training in modern diagnostic and treatment methods.

TB Task Orders: PATH provides short- and long-term technical assistance to countries in Africa, Asia, Eastern Europe, and Latin America to reduce the burden of TB.

Health technologies

PATH develops, adapts, and advances technologies that are innovative, affordable, and appropriate for low-resource settings. Our interventions aim to improve immunization, nutrition, diagnosis, water safety, child survival, and maternal and reproductive health.

Fermentable Starch Oral Rehydration Solution: The goal of this project is to select and demonstrate the efficacy of a new fermentable starch oral rehydration solution through clinical trials to reduce morbidity and mortality from diarrheal disease.

Global Access to Vaccine Adjuvants: PATH works to facilitate global access to new vaccine adjuvants and formulation technologies that can accelerate the development and introduction of critical vaccines.

Health Innovation Portfolio: Our “innovation engine” explores and tests new ideas for technology solutions to global health problems.

Safe Water Project: This project works to bring household water treatment and storage products to the world’s poorest consumers.

Technologies for Health: The HealthTech program has focused on adapting, designing, developing, and advancing technology solutions since 1987.

Maternal and child health

PATH advances promising solutions to address the leading causes of maternal and child death. Our projects focus on safe birth and newborn care, nutrition, and control of diarrheal disease.

Oxytocin Initiative: The project aims to improve maternal health and survival in resource-poor areas of Ghana and India through the safe use of oxytocin.

Ultra Rice® Fortification Technology: The project works to fight malnutrition by expanding the evidence base, developing markets, and broadening market introduction for rice fortified using PATH’s Ultra Rice® fortification technology.

Window of Opportunity Project: This initiative focuses on improving the health and development of children under age two in Mozambique and South Africa.

Reproductive health

PATH works to prevent cervical cancer and sexually transmitted infections, advocates for health services and supplies, addresses family planning needs, introduces contraceptive technologies, and encourages healthy behaviors.

Reproductive Health Supplies Coalition: PATH serves as secretariat for the coalition, which works to ensure access to and use of affordable, high-quality reproductive health commodities.

START-UP: PATH is advancing low-cost molecular tests for the types of human papillomavirus that cause cervical cancer.

Vaccines and immunization

PATH closes gaps in access to lifesaving vaccines. Our projects accelerate vaccine research and development, expand access to new vaccines, and strengthen health systems.

Accelerated Vaccine Introduction (AVI) Initiative: The AVI Technical Assistance Consortium is funded by the GAVI Alliance and led by PATH. It works with partners to build an integrated platform supporting the introduction of pneumococcal and rotavirus vaccines in GAVI-eligible countries.

Advancing Rotavirus Vaccine Development: PATH is working with emerging-country vaccine manufacturers to develop safe, effective, and affordable rotavirus vaccines and help accelerate access to them in developing countries.

Developing Stable Influenza Vaccines: PATH and our partners aim to use advanced vaccine formulation design and stabilization technologies to create influenza vaccine formulations with extended product shelf life.

Enteric Vaccine Initiative: PATH and our partners are advancing vaccines against the leading bacterial causes of diarrheal disease: enterotoxigenic Escherichia coli and Shigella.

Influenza Vaccine Project: We are advancing the development of promising new influenza vaccines, focusing on novel technologies that are accessible, affordable, and available to people in low-resource countries during influenza outbreaks.

Malaria Vaccine Initiative (MVI): MVI’s mission is to accelerate the development of malaria vaccines and to ensure their availability and accessibility in the developing world.

Meningitis Vaccine Project: This partnership between PATH and the World Health Organization (WHO) works to eliminate epidemic meningitis in sub-Saharan Africa by focusing on the development, testing, and introduction of conjugate meningococcal vaccines.

Optimize: This PATH–WHO partnership works to transform the way vaccines and other health products reach underserved populations.

Pneumococcal Vaccine Project: PATH is advancing research and development of new pneumococcal vaccines for infants and children in the developing world.

Cross-program initiative

PATH works at the global and country levels to improve health systems and advance policy priorities.

Advocacy Partnership: Our goal is to accelerate the development and delivery of health innovations through evidence-based advocacy to improve the health of women and children in low-resource settings.

Ultra Rice is a registered US trademark of Bon Dente International, Inc.